Quantitative multiparametric MRI predicts response to neoadjuvant therapy in the community setting.
John VirostkoAnna G SoraceKalina P SlavkovaAnum S KazerouniAngela M JarrettJulie C DiCarloStefanie WoodardSarah AveryBoone GoodgameDebra PattThomas E YankeelovPublished in: Breast cancer research : BCR (2021)
Quantitative analysis of DCE-MRI and DW-MRI can be implemented in the community care setting to accurately predict the response of breast cancer to NAT. Dissemination of quantitative MRI into the community setting allows for the incorporation of these parameters into the standard of care and increases the number of clinical community sites able to participate in novel drug trials that require quantitative MRI.
Keyphrases
- contrast enhanced
- healthcare
- magnetic resonance imaging
- mental health
- diffusion weighted imaging
- high resolution
- palliative care
- computed tomography
- quality improvement
- magnetic resonance
- stem cells
- emergency department
- lymph node
- squamous cell carcinoma
- chronic pain
- young adults
- locally advanced
- mass spectrometry
- health insurance
- adverse drug
- affordable care act
- mesenchymal stem cells
- replacement therapy